Letter of promotion dated October 12, 2021 issued by Reform Biologics, Inc. to Robert Mahoney
EX-10.11 10 d299220dex1011.htm EX-10.11 EX-10.11
Exhibit 10.11
October 12, 2021
Bob Mahoney
Bob
It is with pleasure that I can communicate the following promotion details with you:
| Promotion to CSO effective October 1, 2021 |
| Base salary: $240k |
| Bonus potential: $60k (25% of base) with eligibility starting at the YE2021 review cycle |
| Additional 20,000 shares (stock options) granted |
Sincerely,
/s/ Jeff Hackman |
Jeff Hackman |
CEO |